These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 3654152
1. Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (a phase II trial of the gynecologic oncology group). Muss HB, Bundy BN, Homesley HD, Wilbanks G. Invest New Drugs; 1987; 5(2):199-202. PubMed ID: 3654152 [Abstract] [Full Text] [Related]
2. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. Muss HB, Bundy BN, Christopherson WA. Am J Clin Oncol; 1989 Apr; 12(2):142-4. PubMed ID: 2705404 [Abstract] [Full Text] [Related]
3. Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group. Muss HB, Sutton GP, Bundy B, Hatch KD. Am J Clin Oncol; 1985 Aug; 8(4):312-5. PubMed ID: 3909803 [Abstract] [Full Text] [Related]
4. Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study. Taylor SA, Fleming T, Von Hoff DD, McCracken JD, Bukowski RM, Talley RW, Natale RB, Guy JT, Samlowski WE, Costanzi JH. Invest New Drugs; 1990 Feb; 8(1):77-80. PubMed ID: 2188928 [Abstract] [Full Text] [Related]
5. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group. Muss HB, Blessing JA, Hanjani P, Malfetano JH, Kemp GM, Webster K. Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110 [Abstract] [Full Text] [Related]
6. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study. Slayton RE, Blessing JA, Rettenmaier M, Ball H. Invest New Drugs; 1989 Nov; 7(4):337-40. PubMed ID: 2599803 [Abstract] [Full Text] [Related]
7. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group. Muss HB, Blessing JA, Malfetano J. Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124 [Abstract] [Full Text] [Related]
8. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Rose PG, Blessing JA, Van Le L, Waggoner S. Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702 [Abstract] [Full Text] [Related]
9. Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group. Muss HB, Bundy BN, Adcock L, Beecham J. Am J Clin Oncol; 1990 Feb; 13(1):32-4. PubMed ID: 2154921 [Abstract] [Full Text] [Related]
10. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG). Muss HB, Blessing JA, Eddy GL, McGehee R. Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251 [Abstract] [Full Text] [Related]
11. Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group. Muss HB, Bundy BN, Given FT, Stehman FB. Am J Clin Oncol; 1990 Apr; 13(2):117-8. PubMed ID: 2316480 [Abstract] [Full Text] [Related]
12. Phase II trial of mitoxantrone in advanced gastric cancer. Goldenberg A, Kelsen D, Benedetto P. Oncology; 1988 Apr; 45(4):273-5. PubMed ID: 3290754 [Abstract] [Full Text] [Related]
13. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Schilder RJ, Blessing J, Cohn DE. Gynecol Oncol; 2005 Jan; 96(1):103-7. PubMed ID: 15589587 [Abstract] [Full Text] [Related]
14. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Malfetano JH, Blessing JA, Homesley HD, Hanjani P. Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479 [Abstract] [Full Text] [Related]
15. A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). McGuire WP, Blessing JA, Hatch K, DiSaia PJ. Invest New Drugs; 1986 Feb; 4(2):181-6. PubMed ID: 3733378 [Abstract] [Full Text] [Related]
16. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Arseneau J, Blessing JA, Stehman FB, McGehee R. Invest New Drugs; 1986 Feb; 4(2):187-91. PubMed ID: 3525449 [Abstract] [Full Text] [Related]
17. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Thigpen JT, Blessing JA, Fowler WC, Hatch K. Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650 [Abstract] [Full Text] [Related]
18. Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Rose PG, Blessing JA, Buller RE, Mannel RS, Webster KD. Gynecol Oncol; 2003 May; 89(2):267-70. PubMed ID: 12713990 [Abstract] [Full Text] [Related]
19. Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group Study. Osborne CK, Blumenstein BA, Crawford ED, Weiss GR, Bukowski RM, Larrimer NR. Eur J Cancer; 1992 May; 28(2-3):477-8. PubMed ID: 1591066 [Abstract] [Full Text] [Related]
20. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. McGuire WP, Blessing JA, Yordan E, Beecham J. Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379 [Abstract] [Full Text] [Related] Page: [Next] [New Search]